Mast cell-dependent activation of pro matrix metalloprotease 2: A role for serglycin proteoglycan-dependent mast cell proteases

Biological Chemistry

Volumn 387, Issue 10-11, 2006, Pages 1513-1519

  Lundequist, Anders ^a   Åbrink, Magnus ^a   Pejler, Gunnar ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Chymase; Mast cells; Matrix metalloprotease; Proteoglycan; Serglycin

Indexed keywords

CHYMASE; GELATINASE A; PROTEOGLYCAN; SERGLYCIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL CULTURE; CELL SUBPOPULATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME MODIFICATION; ENZYMOLOGY; EX VIVO STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM CELL; PERITONEUM MAST CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; ENZYME ACTIVATION; HUMANS; MAST CELLS; MATRIX METALLOPROTEINASE 2; MICE; MICE, KNOCKOUT; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOGLYCANS; VESICULAR TRANSPORT PROTEINS;

MURINAE;

EID: 33750625112     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.189     Document Type: Conference Paper

References (31)

1. Abrink, M., Grujic, M., and Pejler, G. (2004). Serglycin is essential for maturation of mast cell secretory granule. J. Biol. Chem. 279, 40897-40905.
2. Caughey, G. (2002). New developments in the genetics and activation of mast cell proteases. Mol. Immunol. 38, 1353-1357.
3. Chancey, A.L., Brower, G.L., and Janicki, J.S. (2002). Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function. Am. J. Physiol. Heart Circ. Physiol. 282, H2152-H2158.
4. Crabbe, T., O'Connell, J.P., Smith, B.J., and Docherty, A.J. (1994). Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A. Biochemistry 33, 14419-14425.
5. Fang, K.C., Raymond, W.W., Blount, J.L., and Caughey, G.H. (1997). Dog mast cell α-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J. Biol. Chem. 272, 25628-25635.
6. Gruber, B.L., Marchese, M.J., Suzuki, K., Schwartz, L.B., Okada, Y., Nagase, H., and Ramamurthy, N.S. (1989). Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest. 84, 1657-1662.
7. Hallgren, J., Estrada, S., Karlson, U., Alving, K., and Pejler, G. (2001). Heparin antagonists are potent inhibitors of mast cell tryptase. Biochemistry 40, 7342-7349.
8. Hernandez-Barrantes, S., Toth, M., Bernardo, M.M., Yurkova, M., Gervasi, D.C., Raz, Y., Sang, Q.A., and Fridman, R. (2000). Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem. 275, 12080-12089.
9. Huhtala, P., Eddy, R.L., Fan, Y.S., Byers, M.G., Shows, T.B., and Tryggvason, K. (1990). Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16. Genomics 6, 554-559.
10. Itoh, Y., Binner, S., and Nagase, H. (1995). Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem. J. 308, 645-651.
11. Jippo, T., Lee, Y.-M., Katsu, Y., Tsujino, K., Morii, E., Kim, D.-K., Kim, H.-M., and Kitamura, Y. (1999). Deficient transcription of mouse mast cell protease 4 gene in mutant mice of mi/mi genotype. Blood 93, 1942-1950.
12. Karlson, U., Pejler, G., Tomasini-Johansson, B., and Hellman, L. (2003). Extended substrate specificity of rat mast cell protease 5, a rodent α-chymase with elastase-like primary specificity. J. Biol. Chem. 278, 39625-39631.
13. Kolset, S.O., Prydz, K., and Pejler, G. (2004). Intracellular proteoglycans. Biochem. J. 379, 217-227.
14. Kunori, Y., Koizumi, M., Masegi, T., Kasai, H., Kawabata, H., Yamazaki, Y., and Fukamizu, A. (2002). Rodent α-chymases are elastase-like proteases. Eur. J. Biochem. 269, 5921-5930.
15. Lutzelschwab, C., Pejler, G., Aveskogh, M., and Hellman, L. (1997). Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations. J. Exp. Med. 185, 13-29.
16. Martignetti, J.A., Aqeel, A.A., Sewairi, W.A., Boumah, C.E., Kambouris, M., Mayouf, S.A., Sheth, K.V., Eid, W.A., Dowling, O., Harris, J., et al. (2001). Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat. Genet. 28, 261-265.
17. Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., and Mignatti, P. (1997). Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 16, 2319-2332.
18. Meier, H.L., Heck, L.W., Schulman, E.S., and MacGlashan, D.W. Jr. (1985). Purified human mast cells and basophils release human elastase and cathepsin G by an IgE-mediated mechanism. Int. Arch. Allergy Appl. Immunol. 77, 179-183.
19. Metcalfe, D.D., Baram, D., and Mekori, Y.A. (1997). Mast cells. Physiol. Rev. 77, 1033-1079.
20. Miller, H.R. and Pemberton, A.D. (2002). Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105, 375-390.
21. Nagase, H. (1997). Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378, 151-160.
22. Overall, C., Wrana, J., and Sodek, J. (1991). Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J. Biol. Chem. 266, 14064-14071.
23. Reponen, P., Sahlberg, C., Huhtala, P., Hurskainen, T., Thesleff, I., and Tryggvason, K. (1992). Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. J. Biol. Chem. 267, 7856-7862.
24. Schechter, N.M., Irani, A.M., Sprows, J.L., Abernethy, J., Wintroub, B., and Schwartz, L.B. (1990). Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J. Immunol. 145, 2652-2661.
25. Sternlicht, M.D. and Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
26. Strongin, A.Y., Collier, I., Bannikov, G., Marmer, B.L., Grant, G.A., and Goldberg, G.I. (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270, 5331-5338.
27. Tchougounova, E., Forsberg, E., Angelborg, G., Kjellen, L., and Pejler, G. (2001). Altered processing of fibronectin in mice lacking heparin. a role for heparin-dependent mast cell chymase in fibronectin degradation. J. Biol. Chem. 276, 3772-3777.
28. Tchougounova, E., Pejler, G., and Abrink, M. (2003). The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover. J. Exp. Med. 198, 423-431.
29. Tchougounova, E., Lundequist, A., Fajardo, I., Winberg, J.O., Abrink, M., and Pejler, G. (2005). A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280, 9291-9296.
30. Wang, Z., Juttermann, R., and Soloway, P.D. (2000). TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem. 275, 26411-26415.
31. Yurt, R.W., Leid, R.W. Jr., Spragg, J., and Austen, K.F. (1977). Immunologic release of heparin from purified rat peritoneal mast cells. J. Immunol. 118, 1201-1207.